Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 92   

Articles published

ARNA 2.75 +0.05 (1.85%)
price chart
Arena Pharmaceuticals, Inc. Short Interest Update
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stated gains of 512,286 shares or 1.8% in the short interest. The short interest registered from 27,821,423 on July 31,2015 to 28,333,709 on August 14,2015.
Arena Pharmaceuticals (ARNA) Rises: Stock Adds 5.7% in Session  Zacks.com
Company Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Drops by -4.26%
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has lost 4.26% during the past week and dropped 25.11% in the last 4 weeks.
Small cap stock picking: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Arrowhead ...
Small cap stock picking: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Arrowhead Research Corp (NASDAQ:ARWR), Omeros Corporation (NASDAQ:OMER).
Zacks Short Term Rating on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
As many as 6 brokerage firms have rated Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) at 2.5. Research Analysts at Zacks have ranked the company at 3, suggesting the traders with a rating of hold for the short term.
Arena Pharmaceuticals Inc (NASDAQ:ARNA) Publicize Second Quarter Results
[PRNewswire] Arena Pharmaceuticals Inc (NASDAQ:ARNA)(TREND ANALYSIS) reported financial results for the second quarter ended June 30, 2015, and provided a corporate update.
Analyst Rating Update on Arena Pharmaceuticals, Inc.  News Watch International
Will Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Beat Analyst Estimates?  Markets Daily
Arena Pharmaceuticals Inc (NASDAQ:ARNA) near 52-week low , short interest down
Arena Pharmaceuticals Inc (NASDAQ:ARNA) (TREND ANALYSIS) shares were traded with a significant increase in volume. The stock closed last trading session at $3.02, down by -6.21%, with a volume of 4,443,906 shares against an average volume for the ...
3 Biotech Stocks Are Getting Crushed: Pharmaceuticals, Inc. (NASDAQ:ARNA ...  Wall Street Point
Healthcare Top Decliners: Omeros Corporation (NASDAQ:OMER), Arena ...  Stock Transcript
Small cap stock picking: Geron Corporation (NASDAQ:GERN), Arena ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) closed at $2.71 with a decrease of 8.59%. The $719.46M company on August 18, 2015 announced that it has partnered with GoodData, a leading provider of Insights-as-a-Service, to create a highly visual ...
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Drops by -11.87%
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has lost 11.87% during the past week and dropped 26.67% in the last 4 weeks.
Disappointing 10-Q Numbers Push Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Down ...
The last few weeks have been shaping up as a real nightmare for investors tracking the chart performance of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA, ARNA message board). The reason: over the last three and a half weeks, ARNA shares have wiped a ...
Arena Pharmaceuticals Inc (NASDAQ:ARNA) Is a Valuable Stock?
[CNW Group] Arena Pharmaceuticals Inc (NASDAQ:ARNA)(TREND ANALYSIS) announced that it has partnered with GoodData, a leading provider of Insights-as-a-Service, to create a highly visual solution that integrates the power of business intelligence ...
Three Biotech Stocks Are Tumbling: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...  Wall Street Point
Morning Best Stocks: USG Corporation (USG), Arena Pharmaceuticals, Inc ...  WallStreet Scope